Literature DB >> 3746360

Clinical significance of serum and CSF findings in the Guillain-Barré syndrome and related disorders.

O G Segurado, H Krüger, H G Mertens.   

Abstract

Clinical data and the serum and cerebrospinal fluid (CSF) findings of 71 patients with Guillain-Barré syndrome (GBS), 7 with Fisher syndrome and 24 with chronic inflammatory polyradiculoneuropathy (CIP), were analysed. Isoelectric focusing of serum and CSF together with different formulae and diagrams were applied to study blood-CSF barrier (BCB) function and possible intrathecal IgG synthesis. The CSF total protein concentration and its IgG percentage depended mainly on the degree of BCB damage, which correlated with the clinical course. Our investigations suggest that oligoclonal IgG of CSF from these patients comes essentially from serum. In the group of GBS patients, oligoclonal IgG was transitory and correlated significantly with the development of BCB damage, cranial neuritis and severity of the disease. CIP patients showed a stable IgG pattern, which varied slightly after immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3746360     DOI: 10.1007/bf00314019

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  37 in total

1.  Chronic inflammatory polyradiculoneuropathy.

Authors:  P J Dyck; A C Lais; M Ohta; J A Bastron; H Okazaki; R V Groover
Journal:  Mayo Clin Proc       Date:  1975-11       Impact factor: 7.616

2.  Intrathecal IgG synthesis in multiple sclerosis and other neurological diseases: a comparative evaluation by IgG-index and isoelectric focusing.

Authors:  M Poloni; B Rocchelli; R Scelsi; P Pinelli
Journal:  J Neurol       Date:  1979-10       Impact factor: 4.849

Review 3.  Multiple sclerosis: the blood-brain-barrier and the measurement of de novo central nervous system IgG synthesis.

Authors:  W W Tourtellotte; B I Ma
Journal:  Neurology       Date:  1978-09       Impact factor: 9.910

4.  Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.

Authors:  G Tibbling; H Link; S Ohman
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

5.  Isoelectric focusing and quantitative estimation of cerebrospinal fluid and serum IgG in idiopathic polyneuropathy.

Authors:  P Livrea; G B Zimatore; I L Simone; M Trojano; V Lepore; V Ferrara; F A Lupo; D Pedone
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

6.  Protein pattern of cerebrospinal fluid in various neurological diseases.

Authors:  C R Hornig; O Busse; W Dorndorf
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1983

7.  The clinical effect and the effect on serum IgG antibodies to peripheral nerve tissue of plasma exchange in patients wit Guillain-Barré syndrome.

Authors:  C A Vedeler; H Nyland; J Fagius; P O Osterman; R Matre; J A Aarli; R W Janzen; H Jacobsen; H Skre
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

8.  Chronic relapsing polyneuritis.

Authors:  J W Prineas; J G McLeod
Journal:  J Neurol Sci       Date:  1976-04       Impact factor: 3.181

9.  Pleocytosis and immunoglobulin changes in cerebrospinal fluid and herpesvirus serology in patients with Guillain-Barré syndrome.

Authors:  H Link; B Wahren; E Norrby
Journal:  J Clin Microbiol       Date:  1979-03       Impact factor: 5.948

10.  Utility of isoelectric focusing of cerebrospinal fluid and serum on agarose evaluated for neurological patients.

Authors:  H Link; V Kostulas
Journal:  Clin Chem       Date:  1983-05       Impact factor: 8.327

View more
  6 in total

1.  Intrathecal rubella antibodies in an adolescent with Guillain-Barré syndrome after mumps-measles-rubella vaccination.

Authors:  M Mühlebach-Sponer; R Zbinden; V A da Silva; H E Gnehm
Journal:  Eur J Pediatr       Date:  1995-02       Impact factor: 3.183

Review 2.  The clinical use of cerebrospinal fluid studies in demyelinating neurological diseases.

Authors:  M G Harrington; P G Kennedy
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

3.  Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases.

Authors:  J Brettschneider; A Claus; J Kassubek; H Tumani
Journal:  J Neurol       Date:  2005-04-01       Impact factor: 4.849

Review 4.  Cerebrospinal fluid biomarkers in Guillain-Barré syndrome--where do we stand?

Authors:  Johannes Brettschneider; Axel Petzold; Sigurd Süssmuth; Hayrettin Tumani
Journal:  J Neurol       Date:  2009-02-16       Impact factor: 4.849

5.  Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With Nusinersen.

Authors:  Claudia D Wurster; Jan C Koch; Isabell Cordts; Jens Dreyhaupt; Markus Otto; Zeljko Uzelac; Simon Witzel; Benedikt Winter; Tugrul Kocak; Michael Schocke; Patrick Weydt; Kurt Wollinsky; Albert C Ludolph; Marcus Deschauer; Paul Lingor; Hayrettin Tumani; Andreas Hermann; René Günther
Journal:  Front Neurol       Date:  2019-11-07       Impact factor: 4.003

6.  A Case of Guillain-Barré Syndrome Associated With COVID-19.

Authors:  Kartikeya Rajdev; Navin Victor; Elaine S Buckholtz; Praveen Hariharan; Muhammad Ahsan Saeed; Daniel M Hershberger; Sabin Bista
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.